Herpes simplex virus hepatitis after renal transplantation.
T
T
Flohr
H
H
Bonatti
H
H
Frierson
R C
RC
Harmon
C
C
Berg
C D
CD
Sifri
P
P
Lobo
T
T
Schmitt
R
R
Sawyer
T
T
Pruett
K
K
Brayman
D000015:Abnormalities, Multiple / Q000628:therapy*; D000208:Acute Disease; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005188:False Negative Reactions; D005260:Female; D006525:Hepatitis, Viral, Human / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D006801:Humans; D007150:Immunohistochemistry; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000009:adverse effects*; D008099:Liver / Q000473:pathology / Q000821:virology; D016133:Polymerase Chain Reaction; D018139:Simplexvirus / Q000302:isolation & purification; D013577:Syndrome; D014564:Urogenital Abnormalities / Q000628:therapy*; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D055815:Young Adult
D000998:Antiviral Agents; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir